
Human CMV pp65 320-328, LMNGQQIFL
Description
About Human CMV pp65 320-328, LMNGQQIFL
The Human Cytomegalovirus (HCMV) (strain AD169) 65 kDa phosphoprotein (pp65) Peptide (IEDB: 38079) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The 65 kDa phosphoprotein (pp65) Peptide, H-LMNGQQIFL-OH (Uniprot: P06725 aa: 320-328) from JPT is produced under strict quality control and quality management.
Human CMV pp65 320-328, LMNGQQIFL - Specifications
- Peptide sequence: H-LMNGQQIFL-OH
- Amount: 10 mg (10 x 1 mg)
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Infection
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Request a Quote for you custom antigen peptide!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for Human CMV pp65 320-328, LMNGQQIFL
References:
Read References with JPT’s Antigen Peptides
Human CMV pp65 320-328, LMNGQQIFL has been described in:
Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers., J Virol, 2003 (PMID: 12692225)
The immunodominant CD8 T cell response to the human cytomegalovirus tegument phosphoprotein pp65(495-503) epitope critically depends on CD4 T cell help in vaccinated HLA-A*0201 transgenic mice., J Immunol, 2011 (PMID: 21810614)
Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines., Eur J Immunol, 2015 (PMID: 25631937)
Documentation
Documentation for Human CMV pp65 320-328, LMNGQQIFL
Properties
Properties of Human CMV pp65 320-328, LMNGQQIFL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Infection |
Layout: | Freeze-dried in glass vial |
Organism: | Human Cytomegalovirus (HCMV) |
Protein Name: | 65 kDa phosphoprotein (pp65) |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to Human CMV pp65 320-328, LMNGQQIFL
Information | Values |
---|---|
Sequence: | H-LMNGQQIFL-OH |
Specifications: | 9mer peptide as TFA salt |